Experimental US HIV Vaccine Regimen Is Safe But Futile

A US HIV vaccine research program was rendered safe but no longer provided protection against HIV infection

 according to a statement from the US National Institute of Physical Fitness (NIH).

The trial, dubbed HPX3002/HVTN 706 or "Mosaic," began in 2019 and involved 3,900 volunteers between

 the ages of 18 and 60 in Europe, the northern and southern US, the Xinhua news company suggested.

The trial was conducted by the HIV Vaccine Trials Community funded by the US National Institute

 Allergy and Infectious Diseases, based at the Fred Hutchinson Cancer Study Center in Seattle.

The experimental vaccine routine was advanced using Janssen. It relied entirely on "mosaic" immunogens,

 HIV subtypes, with the goal of inducing immune responses against a wide variety of global HIV 

To get full information about Health then check link